Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL685935 | 0.84 | PRKCA (0.55) | PRKCATSHRPRKCDPOLBGAA | |
| SCHEMBL9936732 | 0.83 | PRKCA (0.35) | PRKCATSHR | |
| SCHEMBL21501082 | 0.83 | PRKCA (0.50) | PRKCATSHRPRKCDPOLBGAA | |
| SCHEMBL801368 | 0.82 | PRKCA (0.34) | PRKCATSHRMMP8 | |
| SCHEMBL9936885 | 0.81 | TSHR (0.32) | PRKCATSHR | |
| SCHEMBL19596681 | 0.81 | PRKCA (0.48) | PRKCATSHRPRKCDPOLBGAA | |
| SCHEMBL28758524 | 0.81 | PRKCA (0.48) | PRKCATSHRPRKCDPOLBGAA | |
| SCHEMBL13168170 | 0.79 | PRKCA (0.55) | PRKCATSHRPRKCDPOLBGAA | |
| SCHEMBL6871769 | 0.79 | PRKCA (0.52) | PRKCATSHRPRKCDPOLBGAA | |
| SCHEMBL22855965 | 0.79 | PRKCA (0.37) | PRKCAPOLBGAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9440899-B2 | Purification method | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2016-09-13 | — | — | US | disclosed |
| US-9440899-B2 | Purification method | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2016-09-13 | — | — | US | disclosed |
| US-20160168064-A1 | PURIFICATION METHOD | ROHM AND HAAS ELECTRONIC MATERIALS LLC | 2016-06-16 | — | — | US | disclosed |
| US-20160168064-A1 | PURIFICATION METHOD | ROHM AND HAAS ELECTRONIC MATERIALS LLC | 2016-06-16 | — | — | US | disclosed |
| CN-1766733-A | Phototonus resin composition, spacer for display panel and display panel | JSR CORP (JP) | 2006-05-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168064-A1 | PURIFICATION METHOD | ADH1A, ADH5, ADH1C | PRKCA 2479/4885TSHR 2546/4885PRKCD 2751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.